These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 31818695

  • 1. Volumetric PET parameters can predict overall survival in advanced lung adenocarcinoma.
    Yanarateş A, Yazici B.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):3-8. PubMed ID: 31818695
    [Abstract] [Full Text] [Related]

  • 2. [Semiquantitative parameters of 18F-FDG PET/CT, gene mutation states of epidermal growth factor receptor and anaplastic lymphoma kinase in prognosis evaluation of patients with lung adenocarcinoma].
    Liao XH, Wang RF, Liu M, Chen XQ, Xiong Y, Nong L, Yin L, Zhang BY, DU YJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct 20; 53(2):246-254. PubMed ID: 33879893
    [Abstract] [Full Text] [Related]

  • 3. The prognostic role of PET/CT in small-cell lung cancer.
    Budak E, Yanarateş A, Akgün A.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020 Oct 20; 39(1):9-13. PubMed ID: 31865009
    [Abstract] [Full Text] [Related]

  • 4. FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma.
    Chung HW, Lee KY, Kim HJ, Kim WS, So Y.
    J Cancer Res Clin Oncol; 2014 Jan 20; 140(1):89-98. PubMed ID: 24194352
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.
    Acad Radiol; 2013 Jan 20; 20(1):32-40. PubMed ID: 22999369
    [Abstract] [Full Text] [Related]

  • 6. Primary tumor standardized uptake value (SUVmax) measured on 18F-FDG PET/CT and mixed NSCLC components predict survival in surgical-resected combined small-cell lung cancer.
    Hui Z, Wei F, Ren H, Xu W, Ren X.
    J Cancer Res Clin Oncol; 2020 Oct 20; 146(10):2595-2605. PubMed ID: 32494919
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
    Liao S, Penney BC, Wroblewski K, Zhang H, Simon CA, Kampalath R, Shih MC, Shimada N, Chen S, Salgia R, Appelbaum DE, Suzuki K, Chen CT, Pu Y.
    Eur J Nucl Med Mol Imaging; 2012 Jan 20; 39(1):27-38. PubMed ID: 21946983
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC).
    Mirili C, Guney IB, Paydas S, Seydaoglu G, Kapukaya TK, Ogul A, Gokcay S, Buyuksimsek M, Yetisir AE, Karaalioglu B, Tohumcuoglu M.
    Int J Clin Oncol; 2019 Feb 20; 24(2):168-178. PubMed ID: 30109543
    [Abstract] [Full Text] [Related]

  • 10. [Evaluate the value of (18)F-FDG PET-CT imaging in predicting the mutationsin epidermal growth factor receptor in lung adenocarcinoma].
    Ding CY, Yang WP, Guo Z, Sun J, Li YY, Li TR.
    Zhonghua Zhong Liu Za Zhi; 2017 Jul 23; 39(7):528-531. PubMed ID: 28728300
    [Abstract] [Full Text] [Related]

  • 11. 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.
    Zhang F, Wu X, Zhu J, Huang Y, Song X, Jiang L.
    Eur J Nucl Med Mol Imaging; 2021 Sep 23; 48(10):3250-3259. PubMed ID: 33630146
    [Abstract] [Full Text] [Related]

  • 12. Combination of circulating tumor cells and 18F-FDG PET/CT for precision diagnosis in patients with non-small cell lung cancer.
    Sun M, Lu D, Li X, Wang J, Zhang L, Yang P, Yang Y, Shen J.
    Cancer Med; 2024 Sep 23; 13(18):e70216. PubMed ID: 39302034
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.
    Zaizen Y, Azuma K, Kurata S, Sadashima E, Hattori S, Sasada T, Imamura Y, Kaida H, Kawahara A, Kinoshita T, Ishibashi M, Hoshino T.
    Eur J Radiol; 2012 Dec 23; 81(12):4179-84. PubMed ID: 22884163
    [Abstract] [Full Text] [Related]

  • 14. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY, Guo Z, Sun J, Yang WP, Li TR.
    Zhonghua Zhong Liu Za Zhi; 2018 Jul 23; 40(7):528-533. PubMed ID: 30060362
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of metabolic tumor volume and total lesion glycolysis in patients with advanced cervical carcinoma.
    Calles-Sastre L, Mucientes-Rasilla J, San-Frutos Llorente LM, Royuela A, Garcia-Espantaleón Navas M, Herrero Gámiz S, Pérez-Medina T.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019 Jul 23; 38(1):17-21. PubMed ID: 30366731
    [Abstract] [Full Text] [Related]

  • 16. Prognostic impact of the 18F-fluorodeoxyglucose positron-emission tomography/computed tomography metabolic parameters and correlation with hematological inflammatory markers in lung cancer.
    Goksel S, Cengiz A, Ozturk H, Yurekli Y.
    J Cancer Res Ther; 2021 Jul 23; 17(4):925-930. PubMed ID: 34528543
    [Abstract] [Full Text] [Related]

  • 17. Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.
    Wang D, Zhang M, Gao X, Yu L.
    PLoS One; 2016 Jul 23; 11(6):e0158307. PubMed ID: 27336755
    [Abstract] [Full Text] [Related]

  • 18. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
    Salavati A, Duan F, Snyder BS, Wei B, Houshmand S, Khiewvan B, Opanowski A, Simone CB, Siegel BA, Machtay M, Alavi A.
    Eur J Nucl Med Mol Imaging; 2017 Nov 23; 44(12):1969-1983. PubMed ID: 28689281
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH, Chiu NT, Su WC, Guo HR, Lee BF.
    Radiology; 2012 Aug 23; 264(2):559-66. PubMed ID: 22692034
    [Abstract] [Full Text] [Related]

  • 20. The prognostic relationship of 18F-FDG PET/CT metabolic and volumetric parameters in metastatic ALK + NSCLC.
    Agüloğlu N, Aksu A, Unat DS, Akyol M.
    Nucl Med Commun; 2022 Dec 01; 43(12):1217-1224. PubMed ID: 36345766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.